Did the beneficial renal outcomes with vasopressin VANISH?
作者信息
Sacha Gretchen L, Lam Simon W, Bauer Seth R
机构信息
Department of Pharmacy, Cleveland Clinic, Cleveland, Ohio 44195, USA.
出版信息
Ann Transl Med. 2016 Oct;4(Suppl 1):S67. doi: 10.21037/atm.2016.10.59.
Abstract
摘要
相似文献
1
Did the beneficial renal outcomes with vasopressin VANISH?加压素带来的有益肾脏结局消失了吗？
Ann Transl Med. 2016 Oct;4(Suppl 1):S67. doi: 10.21037/atm.2016.10.59.
2
Vasopressin versus noradrenaline as initial therapy in septic shock. Is vasopressin-related renal protection doomed to "vanish" in the haze?血管加压素与去甲肾上腺素作为感染性休克初始治疗的比较。血管加压素相关的肾脏保护作用注定会在迷雾中“消失”吗？
Ann Transl Med. 2016 Oct;4(Suppl 1):S47. doi: 10.21037/atm.2016.10.15.
3
Attempting to define and refine vasopressin use in septic shock: the VANISH trial.试图明确和优化血管加压素在感染性休克中的应用：VANISH试验
Ann Transl Med. 2016 Dec;4(24):501. doi: 10.21037/atm.2016.12.11.
4
Low-dose vasopressin increases glomerular filtration rate, but impairs renal oxygenation in post-cardiac surgery patients.低剂量血管加压素可提高心脏手术后患者的肾小球滤过率，但会损害其肾脏氧合。
Acta Anaesthesiol Scand. 2009 Sep;53(8):1052-9. doi: 10.1111/j.1399-6576.2009.02037.x. Epub 2009 Jun 30.
5
Effects of vasopressin, noradrenalin and oxytocin on blood flow distribution in rat kidney with neoplasm.血管加压素、去甲肾上腺素和催产素对患有肿瘤的大鼠肾脏血流分布的影响。
Acta Radiol Oncol. 1981;20(4):253-60. doi: 10.3109/02841868109130203.
6
Clonidine after renal ischemia to lessen acute renal failure and microvascular damage.肾缺血后使用可乐定以减轻急性肾衰竭和微血管损伤。
Kidney Int. 1980 Sep;18(3):309-22. doi: 10.1038/ki.1980.141.
7
Potential deleterious effects of vasopressin in chronic kidney disease and particularly autosomal dominant polycystic kidney disease.血管加压素在慢性肾脏病、特别是常染色体显性遗传多囊肾病中的潜在有害作用。
Kidney Blood Press Res. 2011;34(4):235-44. doi: 10.1159/000326902. Epub 2011 Jun 21.
8
Immunoreactive vasopressin in end stage renal failure.终末期肾衰竭中的免疫反应性血管加压素
Clin Chim Acta. 1990 Oct 15;190(3):185-8. doi: 10.1016/0009-8981(90)90172-o.
9
Role of afferent renal nerves in the control of vasopressin secretion.肾传入神经在血管加压素分泌控制中的作用。
Chin J Physiol. 1991;34(1):93-104.
10
Renal Outcomes of Vasopressin and Its Analogs in Distributive Shock: A Systematic Review and Meta-Analysis of Randomized Trials.分布性休克中血管加压素及其类似物的肾脏结局：随机试验的系统评价和荟萃分析。
Crit Care Med. 2019 Jan;47(1):e44-e51. doi: 10.1097/CCM.0000000000003471.
引用本文的文献
1
Decreased renal cortical perfusion, independent of changes in renal blood flow and sublingual microcirculatory impairment, is associated with the severity of acute kidney injury in patients with septic shock.肾皮质灌注减少与急性肾损伤的严重程度相关，其与肾血流量变化和舌下微循环障碍无关，发生于感染性休克患者。
Crit Care. 2022 Sep 1;26(1):261. doi: 10.1186/s13054-022-04134-6.
2
Septic acute kidney injury: a review of basic research.脓毒症急性肾损伤：基础研究述评。
Clin Exp Nephrol. 2020 Dec;24(12):1091-1102. doi: 10.1007/s10157-020-01951-3. Epub 2020 Aug 11.
本文引用的文献
1
Effect of Early Vasopressin vs Norepinephrine on Kidney Failure in Patients With Septic Shock: The VANISH Randomized Clinical Trial.血管加压素与去甲肾上腺素对感染性休克患者肾衰竭影响的随机临床试验：VANISH 研究。
JAMA. 2016 Aug 2;316(5):509-18. doi: 10.1001/jama.2016.10485.
2
A comparison of initial monotherapy with norepinephrine versus vasopressin for resuscitation in septic shock.比较脓毒性休克时以去甲肾上腺素与血管加压素进行初始单一疗法的复苏效果。
Ann Pharmacother. 2013 Mar;47(3):301-10. doi: 10.1345/aph.1R442. Epub 2013 Feb 27.
3
Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock: 2012.拯救脓毒症运动：严重脓毒症和脓毒性休克管理国际指南：2012 年。
Crit Care Med. 2013 Feb;41(2):580-637. doi: 10.1097/CCM.0b013e31827e83af.
4
Hospitalizations, costs, and outcomes of severe sepsis in the United States 2003 to 2007.2003 年至 2007 年美国严重脓毒症的住院治疗、费用和结果。
Crit Care Med. 2012 Mar;40(3):754-61. doi: 10.1097/CCM.0b013e318232db65.
5
Concomitant arginine-vasopressin and hydrocortisone therapy in severe septic shock: association with mortality.在严重脓毒性休克中同时使用精氨酸加压素和氢化可的松治疗：与死亡率的关联。
Intensive Care Med. 2011 Sep;37(9):1432-7. doi: 10.1007/s00134-011-2312-3. Epub 2011 Jul 21.
6
Leucyl/cystinyl aminopeptidase gene variants in septic shock.脓毒性休克中的亮氨酰/胱氨酰氨基肽酶基因变异。
Chest. 2011 May;139(5):1042-1049. doi: 10.1378/chest.10-2517. Epub 2011 Feb 17.
7
The effects of vasopressin on acute kidney injury in septic shock.血管加压素对脓毒性休克急性肾损伤的影响。
Intensive Care Med. 2010 Jan;36(1):83-91. doi: 10.1007/s00134-009-1687-x. Epub 2009 Oct 20.
8
Interaction of vasopressin infusion, corticosteroid treatment, and mortality of septic shock.血管加压素输注、皮质类固醇治疗与感染性休克死亡率之间的相互作用。
Crit Care Med. 2009 Mar;37(3):811-8. doi: 10.1097/CCM.0b013e3181961ace.
9
Vasopressin versus norepinephrine infusion in patients with septic shock.脓毒性休克患者中血管加压素与去甲肾上腺素输注的比较。
N Engl J Med. 2008 Feb 28;358(9):877-87. doi: 10.1056/NEJMoa067373.
10
Hydrocortisone therapy for patients with septic shock.氢化可的松治疗感染性休克患者。
N Engl J Med. 2008 Jan 10;358(2):111-24. doi: 10.1056/NEJMoa071366.
Zotero 插件